Predictors of cardiovascular complications in patients with coronary heart disease, atrial fibrillation and various comorbidities

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Objective of the study. To study predictors of cardiovascular complications in patients with coronary heart disease, atrial fibrillation and various comorbidities.

Material and methods. Analysis of the literature data concerning the cardiac-vascular complications in patients with ischemic heart disease, atrial fibrillation and various comorbid pathology was carried out.

Results. The clinical conditions associated with the occurrence of atrial fibrillation are presented. It is shown, that arrhythmogenesis in the specified heart rhythm disorder is multifactorial. It is recognized that structural and electrical remodeling of the myocardium has a definite importance for the occurrence of atrial fibrillation paroxysm, the progression of arrhythmia and the severity of ischemic heart disease.

Conclusion. It is supposed that presented analysis of the literature data concerning investigation of predictors of cardiovascular complications in patients with ischemic heart disease, atrial fibrillation and various comorbic conditions will enable to optimize treatment-and-prophylactic and rehabilitation measures in the specified category of patients.

Full Text

Restricted Access

About the authors

Semen Andreevich Masyukov

Clinic Expert

Author for correspondence.

general practitioner, cardiologist

Russian Federation, Tver, Schweinikov pr., 1


  1. Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.) doi: 10.15829/1560-4071-2020-4076
  2. Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi: 10.15829/1560-4071-2020-4103
  3. Bokeria L.A., Golukhova E.Z., Popov S.V. et al. Clinical practice guidelines for Supraventricular tachycardia in adults. Russian Journal of Cardiology. 2021;26(5):4484. (In Russ.) doi: 10.15829/1560-4071-2021-4484
  4. Dedov D.V., Ivanov A.P., Elgardt I.A. Effect of electromechanical remodeling of the heart on the development of atrial fibrillation in patients with CHD and arterial hypertension. Russian Journal of Cardiology. 2011;16(4): 13–18. (In Russ.)
  5. Kalemberg E.N., Davtyan K.V., Blagova O.V. et al. Relationship between morphological changes in the myocardium and the effectiveness of catheter-assisted pulmonary vein isolation in patients with atrial fibrillation. Russian Journal of Cardiology. 2021;26(2):4283. (In Russ.) doi: 10.15829/1560-4071-2021-4283
  6. Oganov R.G., Denisov I.N., Simanenkov V.I. et al. Сomorbidities in practice. Сlinical guidelines. Cardiovascular Therapy and Prevention. 2017;16(6):5–56. (In Russ.)
  7. Fomina I.G., Dyakova T.A. Left ventricular hypertrophy in arterial hypertension and arrhythmia risk.Cardiovascular Therapy and Prevention. 2006;5(8):83–89. (In Russ.)
  8. Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi: 10.15829/1560-4071-2020-4083
  9. ESC 2020 Guidelines for the Diagnosis and Treatment of Patients with Atrial Fibrillation, developed in collaboration with the European Association for Cardiothoracic Surgery (EACTS). Russian Journal of Cardiology 2021;26(9):4701 (In Russ.) doi: 10.15829/1560-4071-2021-4701
  10. Atrial fibrillation and flutter. Clinical guidelines 2020. Arakelyan M.G., Bokeria L.A., Vasilieva E.Yu. et al. Russian Journal of Cardiology. 2021; 26(7):190-260. (In Russ.) doi: 10.15829/1560-4071-2021-4594.
  11. Dedov D.V., Ivanov A.P., Elgardt I.A. Clinical and functional features and prognosis in patients with atrial fibrillation of different etiology after radiofrequency ablation surgery. Cardiology and cardiovascular surgery. 2011: 4(5): 54–58
  12. Tarasov A.V., Davtyan K.V., Martsevich S.Y. Adverse prognostic factors of the effectiveness of catheter-assisted pulmonary vein occlusion in patients with paroxysmal atrial fibrillation without organic heart disease (PRUF study) Cardiovascular Therapy and Prevention, 2017;16(2):39–45. (In Russ.)
  13. Revishvili A.Sh., Nardaya Sh.G., Rzayev F.G. et al. Electrophysiological and clinical predictors of efficacy of radiofrequency ablation of pulmonary veins and left atrium in patients with persistent atrial fibrillation. Annals of Arrhythmology. 2014;11(1):46–53(In Russ.) doi: 10.15275/annaritmol.2014.1.6.
  14. Dedov, D.V. Ivanov A.P., Elgardt I.A. Atrial fibrillation recurrence risk in patients with coronary heart disease and arterial hypertension according to Holter electrocardiogram monitoring. Bulletin of Arrhythmology. 2010;59:27–32 (In Russ.)
  15. Rogalska E., Tomaszuk-Kazberuk A., Kuzma L. et al. Atrial fibrillation is a predictor of nonobstructive coronary artery disease in elective angiography in old age: a cross-sectional study in Poland and Russia. Aging - Clinical and Experimental Research. 2021. doi: 10.1007/s40520-021-01895-y.
  16. Chaulin A.M., Milyutin I.N., Duplyakov D.V. Comorbidity of chronic obstructive pulmonary disease and cardiovascular disease: prevalence, risk factors and diagnosis. Vrach. 2020; 31(9): 28–34. doi: 10.29296/25877305-2020-09-05

Supplementary files

Supplementary Files
1. Fig. 1

Download (59KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies